Evidence map›Paper›PMID 34868283›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2021

Virucidal activity of oriental hornet

Moustafa Sarhan, Alaa M H El-Bitar, Amaal Mohammadein, Mohammed Elshehaby, Hak Hotta

Open access · goldAbstract read
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Proteomic analyses of venom from a Spider Hawk,The journal of venomous animals and toxins including tropical diseases · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Moustafa SarhanMolecular biology Laboratory, Zoology Department, Faculty of Science, Al-Azhar University, Assiut, Egypt.ORCID 0000-0003-0698-8438
Alaa M H El-BitarDepartment of Microbiology, Kobe University Graduate School of Medicine, Kobe, Japan.
Amaal MohammadeinZoology Department, Faculty of Science, Zagazig University, Zagazig, Egypt.
Mohammed ElshehabyZoology Department, Faculty of Science, Al-Azhar University, Assiut, Egypt.
Hak HottaDepartment of Microbiology, Kobe University Graduate School of Medicine, Kobe, Japan.
Al-Azhar University · EGKonan Women's University · JPZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) infection is a major worldwide health problem that can cause liver fibrosis and hepatocellular carcinoma (HCC). The clinical treatment of HCV infection mainly relies on the use of direct-acting antivirals (DAAs) that are usually expensive and have side effects. Therefore, achieving the discovery of more successful agents is always urgent. In this context, antiviral compounds that inhibit viral infections and disease progression with important therapeutic activities have been identified in animal venoms including arthropod toxins. This indicates that arthropod venoms represent a good natural source of promising candidates for new antivirals.

methodsThe antiviral activity of the wasp venom (WV), isolated from the Oriental hornet (

resultsThe results revealed that WV inhibited HCV infectivity with 50% inhibitory concentration (IC

conclusionWV can inhibit the entry stage of HCV infection at non-cytotoxic concentrations. Therefore, it could be considered a potential candidate for characterization of natural anti-HCV agents targeting the entry step.

Indexed as

Antiviral activityHepatitis C virus (HCV)Vespa orientalisWasp venom

Identifiers

PMID34868283
PMCPMC8609606
OpenAlexW3215795342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.